The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis

Published:2017-11-14 Issue:1 Volume:130 Page:129-136
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Zhou Junteng¹,Zhang Qi²,Wang Yushu¹,Gao Peijuan³,Chen Decai²

Affiliation:

1. Department of Cardiology, Sichuan University West China Hospital, Chengdu, China

2. Department of Endocrinology and Metabolism, Sichuan University West China Hospital, Chengdu, China

3. Department of Nephrology, Sichuan University West China Hospital, Chengdu, China

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2018.1401421

Reference48 articles.

1. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

2. Forecasting the Future of Cardiovascular Disease in the United States

3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

4. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?;International Journal of Molecular Sciences;2024-03-21

2. Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense?;Journal of Clinical Medicine;2024-01-28

3. Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting;Biomedicines;2023-12-12

4. Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods;International Journal of Molecular Sciences;2023-09-09

5. Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a);International Journal of Molecular Sciences;2023-09-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3